Projects per year
Organization profile
Organization profile
At UT Health San Antonio MD Anderson Cancer Center, our patient-and-family-centered care means including those closest to the patient in all care and treatment decisions. This increased level of communication leads to deeper connections between the care teams and the patients, more satisfied patients and better outcomes. Our multidisciplinary approach to cancer care allows our teams to customize treatments according to each individual and their personal cancer journey.
As the only National Cancer Institute-designated cancer center in South Texas, we contributeto the rapid pace of discovering the underlying causes of and treatments for cancer—so that our patients have access to more than 200 clinical trials specifically focused on cancer right here in San Antonio. These clinical trials can provide treatment options for patients at every stage of their disease. Our ongoing commitment to research is part of our mission to advance cancer care for every patient, every day.
Fingerprint
Dive into the research topics where Mays Cancer Center is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer
Project: Research project
-
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
Project: Research project
-
Inhibition of Autophagy: A Novel Therapeutic Strategy for Advanced Solid Tumors
Project: Research project
-
A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment
Weiss, M. C., Hibbs, J. E., Buckley, M. E., Danese, S. R., Leitenberger, A., Bollmann-Jenkins, M., Meske, S. W., Aliano-Ruiz, K. E., McHugh, T. W., Larson, S. L., Le, E. H., Green, N. L., Gilman, P. B., Kaklamani, V. G., Chlebowski, R. T. & Martinez, D. M., Jan 1 2022, In: Cancer. 128, 1, p. 160-168 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells
Sareddy, G. R., Pratap, U. P., Venkata, P. P., Zhou, M., Alejo, S., Viswanadhapalli, S., Tekmal, R. R., Brenner, A. J. & Vadlamudi, R. K., May 2021, In: Stem Cells. 39, 5, p. 536-550 15 p.Research output: Contribution to journal › Article › peer-review
-
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)
Argiris, A., Miao, J., Cristea, M. C., Chen, A. M., Sands, J. M., Decker, R. H., Gettinger, S. N., Daly, M. E., Faller, B. A., Albain, K. S., Yanagihara, R. H., Garland, L. L., Byers, L. A., Wang, D., Koczywas, M., Redman, M. W., Kelly, K. & Gandara, D. R., Jul 2021, In: Clinical Lung Cancer. 22, 4, p. 313-323.e1Research output: Contribution to journal › Article › peer-review